DNA Capital
Private equityPre-Seed–Late Stage
Frequently asked questions
- What stage does DNA Capital invest at?
- DNA Capital invests at the Pre-Seed, Seed, Late Stage stages.
- What is DNA Capital's typical check size?
- DNA Capital typically writes checks of $100K – $5M.
- What sectors does DNA Capital focus on?
- DNA Capital focuses on Healthtech.
- Does DNA Capital lead rounds?
- Yes, DNA Capital leads investment rounds.
Similar investors
8VC is a technology investment firm focused on building and investing in ambitious companies across life sciences, healthcare, manufacturing, enterprise, logistics, and defense sectors, with particular emphasis on operational intelligence and data-driven decision-making.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
Octopus Ventures is a pan-European early-stage venture capital firm that invests from pre-seed through Series A and beyond, with pre-seed investments typically at £100k and later-stage investments starting at £1 million.